FOUNDATION MEDICINE, INC. FMI Balance Sheet

Foundation medicine, inc. (FMI)

Balance Sheet / Quarterly

Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Dec'12
Assets
Current assets:
Cash and cash equivalents
53,418	60,293	71,404	76,814	36,532	49,075	63,617	77,847	62,282	86,058	117,763	250,162	263,596	61,700	72,080	86,661	97,054	110,308	124,293	137,927	54,838
Marketable securities
-	-	-	-	34,985	49,976	79,402	90,038	128,130	127,441	89,607	-	-	-	-	-	-	-	-	-	-
Short-term restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	161	-
Accounts receivable
40,939	32,222	19,967	13,293	13,645	5,858	8,206	6,901	10,418	8,201	7,362	10,071	9,987	10,673	9,894	6,011	6,067	7,960	6,262	4,437	2,195
Receivable due from Roche
11,402	9,099	10,159	2,203	4,082	4,870	2,007	6,817	2,030	2,368	403	-	4,149	-	-	-	-	-	-	-	-
Inventory
25,815	16,411	13,171	10,400	8,922	10,349	10,438	11,959	10,160	6,743	7,992	9,460	6,142	4,493	4,809	4,194	2,593	2,973	1,763	942	803
Prepaid expenses and other current assets
5,641	13,003	9,118	4,612	5,102	5,338	5,251	2,973	3,829	5,088	6,517	6,120	5,675	3,981	2,865	1,471	1,191	1,256	992	950	550
Total current assets
137,215	131,028	123,819	107,322	103,268	125,466	168,921	196,535	216,849	235,899	229,644	275,813	289,549	80,847	89,648	98,337	106,905	122,497	133,310	144,417	58,386
Marketable securities
-	-	-	-	-	-	-	-	-	-	24,939	-	-	-	-	-	-	-	-	-	-
Property and equipment, net
50,778	41,607	41,119	39,136	38,713	39,553	41,486	42,041	41,211	41,104	41,333	36,774	30,971	25,131	21,015	21,139	21,696	22,277	22,104	19,480	7,465
Restricted cash
2,305	2,305	2,305	2,305	-	-	1,395	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	2,305	1,395	-	1,395	1,395	1,395	1,395	1,395	1,395	1,394	864	1,725	1,725	1,725	1,725	1,725	161
Other assets
3,142	2,225	1,760	1,796	2,080	2,140	2,233	2,345	2,160	2,155	678	1,026	885	486	411	375	321	121	129	54	27
Total assets
193,440	177,165	169,003	150,559	146,366	168,554	214,035	242,316	261,615	280,553	297,989	315,008	322,800	107,858	111,938	121,576	130,647	146,620	157,268	165,676	66,039
Liabilities and stockholders (deficit) equity
Current liabilities:
Accounts payable
28,834	25,865	21,926	16,178	15,175	10,427	11,898	12,005	10,847	8,518	10,469	11,963	9,357	9,416	7,263	5,548	5,491	5,245	7,007	3,339	1,609
Accrued expenses and other current liabilities
32,256	22,393	36,745	28,246	25,269	19,240	20,578	22,263	14,675	14,290	12,822	16,069	10,752	12,201	7,414	7,147	4,747	7,506	5,168	5,022	3,463
Deferred revenue
10,720	2,867	2,212	1,702	1,926	1,985	2,104	2,156	1,184	1,797	717	455	127	183	340	898	693	807	918	1,304	1,622
Roche related-party deferred revenue
8,190	4,801	3,742	296	3,742	293	3,747	295	3,742	230	3,742	-	-	-	-	-	-	-	-	-	-
Current portion of deferred rent
1,854	1,836	1,818	1,439	1,384	2,418	2,324	2,250	2,209	2,184	2,146	2,094	1,908	1,586	1,429	1,276	1,178	1,167	1,167	149	132
Current portion of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	298	576	1,058	1,499	1,540	1,704
Total current liabilities
81,854	57,762	66,443	47,861	47,496	34,363	40,651	38,969	32,657	27,019	29,896	30,581	22,144	23,386	16,446	15,167	12,685	15,783	15,759	11,354	8,530
Deferred rent, net of current portion and other non-current liabilities
10,122	10,507	10,892	9,261	9,354	7,874	8,538	8,971	9,350	9,801	10,404	10,953	11,092	9,656	9,323	-	-	-	-	-	-
Indebtedness to Roche - non-current
110,000	90,000	60,000	30,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total liabilities
-	-	-	-	-	-	-	-	-	-	-	41,534	33,236	33,042	-	-	-	-	-	-	-
Deferred rent, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,365	9,592	9,837	9,710	11,147	287
Deferred revenue, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	375	429	592	-	26	156
Notes payable, net of current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	397	1,441
Warrant to purchase preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	225
Restricted stock liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	12	19	73	88	107	139
Commitments and contingencies (Note 15)
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders (deficit) equity:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; no shares issued and outstanding at September 30, 2016 and December 31, 2015
-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0
Common stock, $0.0001 par value, 150,000,000 shares authorized; 37,147,273 and 36,541,770 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively
4	4	4	4	4	4	4	4	4	3	3	3	3	3	3	3	3	3	3	3	-
Additional paid-in capital
550,511	544,541	537,904	531,593	525,041	517,698	509,664	503,537	497,462	492,667	489,480	486,067	481,561	233,763	228,151	-	-	-	-	-	-
Accumulated other comprehensive (loss) income
-200	-177	109	78	65	-49	-14	34	59	-14	-178	-	-	-	-	-	-	-	-	-	-
Additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	225,342	223,627	222,261	221,471	219,314	3,422
Accumulated deficit
-558,851	-525,472	-506,349	-468,238	-435,594	-391,336	-344,808	-309,199	-277,917	-248,923	-231,616	-212,596	-192,000	-158,950	-141,985	-128,688	-115,708	-101,929	-89,763	-76,672	-46,819
Total stockholders (deficit) equity
-8,536	18,896	31,668	63,437	89,516	126,317	164,846	194,376	219,608	243,733	257,689	273,474	289,564	74,816	86,169	96,657	107,922	120,335	131,711	142,645	-43,397
Total liabilities and stockholders (deficit) equity
193,440	177,165	169,003	150,559	146,366	168,554	214,035	242,316	261,615	280,553	297,989	315,008	322,800	107,858	111,938	121,576	130,647	146,620	157,268	165,676	66,039